Newsfeeds Archive - Spark Newswire

1 minute read

Monopar To Present Data Showcasing The Appeal Of uPAR As A Radiopharma Cancer Target And Of Its Lead Clinical Program At The 2024 SNMMI Annual Meeting

June 10, 8:06 AM

Monopar Therapeutics Inc. (NASDAQ:MNPR), a clinical-stage radiopharmaceutical company focused on developing innovative treatments for cancer patients, is presenting today data from the preclinical development of its

MNPR

1 minute read

Movers

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights

June 7, 8:08 AM

Gainers Venus Concept (NASDAQ:VERO) shares increased by 135.2% to $1.38 during Friday’s pre-market session. The market value of…

ANL

2 minute read

Monopar Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying

By Avi Kapoor

June 3, 7:41 AM

The Dow Jones index closed higher by around 575 points on Friday. When insiders purchase or sell shares,…

FRTX

2 minute read

Movers

12 Health Care Stocks Moving In Thursday’s After-Market Session

By Benzinga Insights

May 9, 4:31 PM

Gainers Sensus Healthcare (NASDAQ:SRTS) shares increased by 33.3% to $5.08 during Thursday’s after-market session. The market value of…

ADMA

1 minute read

Monopar Announces Filing Of Patent Protecting MNPR-101 Radiopharma Optimization Findings

By Benzinga Newsdesk

April 16, 8:05 AM

Monopar Therapeutics Inc. (NASDAQ:MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients, today announced that it has filed a provisional patent application

MNPR

1 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s After-Market Session

By Benzinga Insights

February 20, 5:31 PM

Gainers Motus GI Hldgs (NASDAQ:MOTS) shares rose 53.3% to $1.0 during Tuesday’s after-market session. The company’s market cap…

AFIB

2 minute read

Crude Oil Moves Lower; Summit Therapeutics Shares Plummet

By Avi Kapoor

February 20, 3:33 PM

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 200 points on Tuesday. The Dow traded down 0.18% to 38,557.86 while the NASDAQ fell 1.30% to 15,570.84. The S&P 500 also fell, dropping, 0.73% to 4,969.26.

BFRI

4 minute read

Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

By Avi Kapoor

February 20, 2:21 PM

Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.

AGRI

1 minute read

Why Is Cancer Drug Focused Monopar Therapeutics Stock Trading Higher On Tuesday?

By Vandana Singh

February 20, 1:48 PM

Monopar Therapeutics surges 90% premarket with 3.94 million volume after HREC clearance for Phase 1 dosimetry trial (MNPR-101-Zr) in advanced cancers.

MNPR